Computerized Anesthesia System Identifies Epidural Space
|
By HospiMedica International staff writers Posted on 08 Aug 2017 |
|
Image: The CompuFlo Epidural Computer Controlled Anesthesia System (Photo courtesy of Milestone Medical).
A novel anesthesia system provides objective visual and audible pressure feedback, allowing anesthesiologists to correctly identify the epidural space.
The CompuFlo Epidural Computer Controlled Anesthesia System is intended for use with an epidural needle for real-time verification of needle tip placement in the lumbar epidural space in adult patients. The system uses proprietary dynamic pressure sensing (DPS) technology to verify correct placement; once confirmed, the CompuFlo system is disconnected. The system includes an injection-molded plastic housing that contains the motor-driven piston syringe pumps and internal force sensor, syringe retainer, microprocessor, and a liquid crystal display (LCD) screen display.
A complimentary tray of single-use disposable supplies includes an external in-line fluid pressure sensor, a 20 mL plastic syringe, and a tubing set and adapter that limit use of the disposables; epidural needles and the injectable solution are not supplied in the disposable kit. The CompuFlo system is not intended for medication infusion, must not be used on patients with skin conditions in the lumbar region greater than four cm2, or in patients with prior surgery in the lumbar area that prevents epidural access. The CompuFlo Epidural system is a product of Milestone Scientific (Livingston, NJ, USA), and has been approved by the U.S. Food and Drug Administration (FDA).
“Milestone's painless and precise computerized injection technology platform has the potential to transform drug delivery. Over the coming years, we will be laser-focused on sales and marketing activities, including building our global distribution network,” said Daniel Goldberger, CEO of Milestone Scientific. “Following our recent FDA marketing clearance of the epidural instrument, I look forward to now converting the growing enthusiasm among medical practitioners into broad global commercial adoption.”
“For the first time you precisely can control the rate of administration of a drug, but more importantly you can precisely monitor and control fluid pressure,” said Mark Hochman, MD, director of clinical affairs at Milestone Scientific. “We embarked upon a research project to determine what benefits could be realized from controlling and monitoring both flow-rate and fluid pressure as any drug leaves the needle into a tissue space. That led to the development of a technology that has numerous applications for an unlimited number of different injections.”
Related Links:
Milestone Scientific
The CompuFlo Epidural Computer Controlled Anesthesia System is intended for use with an epidural needle for real-time verification of needle tip placement in the lumbar epidural space in adult patients. The system uses proprietary dynamic pressure sensing (DPS) technology to verify correct placement; once confirmed, the CompuFlo system is disconnected. The system includes an injection-molded plastic housing that contains the motor-driven piston syringe pumps and internal force sensor, syringe retainer, microprocessor, and a liquid crystal display (LCD) screen display.
A complimentary tray of single-use disposable supplies includes an external in-line fluid pressure sensor, a 20 mL plastic syringe, and a tubing set and adapter that limit use of the disposables; epidural needles and the injectable solution are not supplied in the disposable kit. The CompuFlo system is not intended for medication infusion, must not be used on patients with skin conditions in the lumbar region greater than four cm2, or in patients with prior surgery in the lumbar area that prevents epidural access. The CompuFlo Epidural system is a product of Milestone Scientific (Livingston, NJ, USA), and has been approved by the U.S. Food and Drug Administration (FDA).
“Milestone's painless and precise computerized injection technology platform has the potential to transform drug delivery. Over the coming years, we will be laser-focused on sales and marketing activities, including building our global distribution network,” said Daniel Goldberger, CEO of Milestone Scientific. “Following our recent FDA marketing clearance of the epidural instrument, I look forward to now converting the growing enthusiasm among medical practitioners into broad global commercial adoption.”
“For the first time you precisely can control the rate of administration of a drug, but more importantly you can precisely monitor and control fluid pressure,” said Mark Hochman, MD, director of clinical affairs at Milestone Scientific. “We embarked upon a research project to determine what benefits could be realized from controlling and monitoring both flow-rate and fluid pressure as any drug leaves the needle into a tissue space. That led to the development of a technology that has numerous applications for an unlimited number of different injections.”
Related Links:
Milestone Scientific
Gold Member
12-Channel ECG
CM1200B
New
Medical Adhesive
MED 5570U
New
X-Ray Generator
Advantage Plus Generators
Latest Critical Care News
- Automated IV Labeling Solution Improves Infusion Safety and Efficiency
- First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
- AI Helps Predict Which Heart-Failure Patients Will Worsen Within a Year
- Algorithm Allows Paramedics to Predict Brain Damage Risk After Cardiac Arrest
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read more
Surgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
